Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:25 am Sale |
2022-12-31 | 13G | Ardelyx, Inc. ARDX |
Deep Track Capital, LP | 0 0.000% |
-14,252,831 (Position Closed) |
Filing History |
| 2023-02-14 08:24 am Purchase |
2022-12-31 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 4,899,179 5.750% |
380,604 (+8.42%) |
Filing History |
| 2023-02-14 08:23 am Purchase |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,704,000 8.230% |
579,579 (+51.54%) |
Filing History |
| 2023-02-14 08:23 am Purchase |
2022-12-31 | 13G | Agenus Inc. AGEN |
Deep Track Capital, LP | 1,375,650 8.860% |
599,723 (+77.29%) |
Filing History |
| 2023-02-14 08:21 am Purchase |
2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 3,952,000 9.660% |
1,537,083 (+63.65%) |
Filing History |
| 2023-02-03 4:31 pm Purchase |
2023-02-03 | 13G | Structure Therapeutics Inc. GPCR |
Deep Track Capital, LP | 7,940,346 7.610% |
7,940,346 (New Position) |
Filing History |
| 2023-01-13 4:14 pm Purchase |
2023-01-06 | 13G | Geron Corporation GERN |
Deep Track Capital, LP | 24,022,883 5.350% |
24,022,883 (New Position) |
Filing History |
| 2022-12-22 4:02 pm Purchase |
2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 1,816,531 7.320% |
1,816,531 (New Position) |
Filing History |
| 2022-12-19 4:11 pm Purchase |
2022-12-09 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,000,000 9.030% |
15,000,000 (New Position) |
Filing History |
| 2022-10-28 4:10 pm Purchase |
2022-10-18 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Deep Track Capital, LP | 7,841,570 5.530% |
7,841,570 (New Position) |
Filing History |
| 2022-10-21 4:01 pm Purchase |
2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,481,000 8.250% |
2,481,000 (New Position) |
Filing History |
| 2022-10-20 4:00 pm Purchase |
2022-10-10 | 13G | Immunic, Inc. IMUX |
Deep Track Capital, LP | 4,022,989 9.290% |
4,022,989 (New Position) |
Filing History |
| 2022-10-07 4:02 pm Purchase |
2022-09-29 | 13G | Valneva SE VALN |
Deep Track Capital, LP | 10,513,265 7.600% |
10,513,265 (New Position) |
Filing History |
| 2022-10-03 4:37 pm Purchase |
2022-09-23 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,124,421 5.460% |
1,124,421 (New Position) |
Filing History |
| 2022-09-30 4:03 pm Purchase |
2022-09-22 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 4,518,575 5.330% |
4,518,575 (New Position) |
Filing History |
| 2022-09-23 4:11 pm Purchase |
2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX |
Deep Track Capital, LP | 3,374,394 5.340% |
3,374,394 (New Position) |
Filing History |
| 2022-09-19 4:07 pm Purchase |
2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Deep Track Capital, LP | 699,281 9.990% |
699,281 (New Position) |
Filing History |
| 2022-09-16 4:08 pm Purchase |
2022-09-06 | 13G | IVERIC bio, Inc. ISEE |
Deep Track Capital, LP | 9,000,000 7.620% |
9,000,000 (New Position) |
Filing History |
| 2022-09-12 4:19 pm Purchase |
2022-09-02 | 13G | Ardelyx, Inc. ARDX |
Deep Track Capital, LP | 14,252,831 8.450% |
14,252,831 (New Position) |
Filing History |
| 2022-08-22 4:16 pm Purchase |
2022-08-12 | 13G | Vigil Neuroscience, Inc. VIGL |
Deep Track Capital, LP | 3,684,619 9.990% |
3,684,619 (New Position) |
Filing History |